Atomo NewsGet the app

Get the latest Science News and Discoveries

Insilico Medicine receives IND approval from FDA for ISM8969, an AI-empowered potential best-in-class NLRP3 inhibitor - EurekAlert!


Comprehensive up-to-date news coverage, aggregated from sources all over the world by Google News.

None

Get the Android app

Or read this on Eureka Alert

Read more on:

Photo of FDA

FDA

Photo of class

class

Photo of Insilico Medicine

Insilico Medicine

Related news:

News photo

Insilico Medicine to present three abstracts at the 2026 Crohn’s & Colitis Congress highlighting clinical, preclinical safety, and efficacy data for ISM5411, a novel gut-restricted PHD1/2 inhibitor for inflammatory bowel disease - EurekAlert!

News photo

RFK Jr. Orders Study on Cellphone Radiation as FDA Drops Assurance That Phones Are Not Dangerous

News photo

Insilico Medicine integrates Nach01 Foundation Model with Microsoft Discovery to enable AI-native, enterprise-ready drug discovery workflows - EurekAlert!

« How molecules move in extreme water environments depends on their shape - EurekAlert!
This form of therapy can save enormous amounts of money by getting people with mental health problems back to work more quickly - EurekAlert! »